Shenzhen YHLO Biotech (SH:688575) 梧桐树下V·2026-03-02 07:35Core Viewpoint - Shenzhen Yahui Long Biotechnology (688575) is facing administrative penalties from the Shenzhen Securities Regulatory Bureau for misleading disclosures regarding a strategic cooperation agreement, which led to significant stock price fluctuations [1][5]. Group 1: Administrative Penalties - On February 28, 2026, the company received a notice of administrative penalties, indicating that it is suspected of violating information disclosure regulations [2]. - The penalties include a warning and a fine of 4 million yuan for the company, 2 million yuan for Chairman Hu Kunhui, and 1.5 million yuan for Secretary Wang Mingyang, totaling 7.5 million yuan [1][6]. Group 2: Disclosure Violations - The company inaccurately disclosed information about its strategic cooperation with Shenzhen Brain Machine Star Chain Technology Co., Ltd., particularly regarding the development status of products [3][4]. - The initial announcement and subsequent supplementary disclosures failed to accurately reflect the actual development stages of the products, which could mislead investors [5][6]. Group 3: Financial Performance - For the fiscal year 2025, the company reported a total revenue of 201,162.03 million yuan, a decrease of 10.07% year-on-year [7][8]. - The net profit attributable to the parent company was -92.03 million yuan, marking a significant decline of 30,153.36% compared to the previous year [8].